Monday, Oct 5, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | World | Covid Jabs For Kids Pfizer To Seek Approval In Sep

Covid jabs for kids: Pfizer to seek approval in Sep

By early next week, the company is expected to get FDA approval for emergency use of its vaccine in children 12 to 15 years old.

By Agencies
Updated On - 11 June 2021, 11:43 AM
Covid jabs for kids: Pfizer to seek approval in Sep
whatsapp facebook twitter telegram

Washington: Pharmaceutical major Pfizer will likely seek the US Food and Drug Administration’s emergency authorization to administer its coronavirus vaccine among children between the ages of 2 and 11 in September, the media reported.

By early next week, the company is expected to get FDA approval for emergency use of its vaccine in children 12 to 15 years old.


It is planning to apply for full approval of the vaccine for use in people from ages 16 to 85, this month, The New York Times reported. The pharma major will also have clinical trial data on the safety of its vaccine in pregnant women by early August.

The FDA is preparing to make Covid vaccines “accessible to additional, younger populations”, Jen Psaki, the White House press secretary, was quoted as saying at a news conference on Tuesday, the report said.

Currently, the Pfizer-BioNTech vaccine is given to adults under an emergency use authorization that the companies received in December. Obtaining full FDA approval will allow it to market the vaccine directly to consumers.

“Full approval is a welcome indicator of the continued safety and efficacy of the Pfizer vaccine,” Saskia Popescu, an infectious disease epidemiologist at George Mason University, was quoted as saying.

Earlier in March, results of a clinical trial led by the companies showed that the Pfizer-BioNTech coronavirus vaccine is extremely effective in young adolescents, even more than in adults. The children produced strong antibody responses and experienced no serious side effects.

Vaccinating adolescents may also be key to boost immunity levels in the general population and thus reduce the number of hospitalisation and death.

A full approval may also make it easier for companies, government agencies, schools to get vaccinated and the jabs will stay in the market, even after the end of the pandemic, the report said.

  • Follow Us :
  • Tags
  • Coronavirus
  • emergency authorization
  • Pfizer
  • Pharmaceutical

Related News

  • India excluded as US expands visa-bond requirement to 50 countries

    India excluded as US expands visa-bond requirement to 50 countries

  • Trump predicts short-lived Iran conflict, says situation ‘working out very well’

    Trump predicts short-lived Iran conflict, says situation ‘working out very well’

  • OpenAI shelves new model after safety tests

    OpenAI shelves new model after safety tests

  • US to host G20 trade talks in Milwaukee next week

    US to host G20 trade talks in Milwaukee next week

Latest News

  • Birthday outing ends in tragedy; girl, relative killed in Tank Bund accident

    2 hours ago
  • Andhra to build houses for poor using 3D concrete-printing technology

    2 hours ago
  • Yemen’s Houthis claim missile, drone strikes on Saudi Aramco facilities

    2 hours ago
  • Janhvi Kapoor condemns viral deepfake clip, says it borders on sexual assault

    3 hours ago
  • Opinion: India’s inclusive education gap—why putting children in classrooms is not enough

    3 hours ago
  • Tiruchanur temple elephant Srinidhi attacks caretaker, injures him

    3 hours ago
  • Editorial: A hero in the skies

    3 hours ago
  • Rahul Gandhi ignored Indian Hero Captain Smit Machchhar, says Bandi Sanjay

    4 hours ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam

Telangana Today App